By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
NewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोतNewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोतNewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोत
  • मनोरंजन
    मनोरंजनShow More
    संतोष बलराज – एक नज़र: करियर, उथल‑पुथल और दुःखदंत निधन
    संतोष बलराज – एक नज़र: करियर, उथल‑पुथल और दुःखदंत निधन
    5 August 2025
    शानवास बने मराठी सिनेमा के यादगार चेहरे — निधन 71 वर्ष की आयु में
    शानवास बने मराठी सिनेमा के यादगार चेहरे — निधन 71 वर्ष की आयु में
    5 August 2025
    उत्तरकाशी 2025: क्लाउडबर्स्ट से तबाही, सिलक्यारा सुरंग में नया मोड़
    उत्तरकाशी 2025: क्लाउडबर्स्ट से तबाही, सिलक्यारा सुरंग में नया मोड़
    5 August 2025
    सत्यपाल मलिक का निधन: जम्मू-कश्मीर के पूर्व राज्यपाल ने अंतिम सांस ली
    सत्यपाल मलिक का निधन: जम्मू-कश्मीर के पूर्व राज्यपाल ने अंतिम सांस ली
    5 August 2025
    भारत के आगामी क्रिकेट मैच 2025: एशिया कप से लेकर ऑस्ट्रेलिया टूर तक का पूरा शेड्यूल
    भारत के आगामी क्रिकेट मैच 2025: एशिया कप से लेकर ऑस्ट्रेलिया टूर तक का पूरा शेड्यूल
    5 August 2025
  • फाइनेंस
    फाइनेंसShow More
    GNG Electronics IPO: ₹355 पर दमदार लिस्टिंग, 150 गुना सब्सक्रिप्शन – निवेशकों के लिए क्या है अगला कदम?
    GNG Electronics IPO: ₹355 पर दमदार लिस्टिंग, 150 गुना सब्सक्रिप्शन – निवेशकों के लिए क्या है अगला कदम?
    5 August 2025
    JioBlackRock AMC की पहली NFO – 5 इंडेक्स फंड्स लॉन्च
    JioBlackRock AMC की पहली NFO – 5 इंडेक्स फंड्स लॉन्च
    5 August 2025
    JSW Cement IPO 2025: प्राइस बैंड ₹139–₹147, GMP ₹18–₹19, लिस्टिंग 14 अगस्त को संभावित
    JSW Cement IPO 2025: प्राइस बैंड ₹139–₹147, GMP ₹18–₹19, लिस्टिंग 14 अगस्त को संभावित
    5 August 2025
    TCS कर्मचारी की फुटपाथ पर नींद: वेतन विवाद की चौंकाने वाली कहानी
    TCS कर्मचारी की फुटपाथ पर नींद: वेतन विवाद की चौंकाने वाली कहानी
    5 August 2025
    Highway Infrastructure IPO 2025: सब्सक्रिप्शन, GMP और भविष्य की संभावनाएँ
    Highway Infrastructure IPO 2025: सब्सक्रिप्शन, GMP और भविष्य की संभावनाएँ
    5 August 2025
  • एजुकेशन
    एजुकेशनShow More
    DSSSB Non-Teaching भर्ती 2025: 600+ पदों पर आवेदन शुरू, 10वीं पास के लिए सुनहरा मौका
    DSSSB Non-Teaching भर्ती 2025: 600+ पदों पर आवेदन शुरू, 10वीं पास के लिए सुनहरा मौका
    5 August 2025
    BSF Constable Tradesman भर्ती 2025: 3,588 पदों पर निकली वैकेंसी, आवेदन की अंतिम तिथि 23 अगस्त
    BSF Constable Tradesman भर्ती 2025: 3,588 पदों पर निकली वैकेंसी, आवेदन की अंतिम तिथि 23 अगस्त
    5 August 2025
    AIIMS Nursing Officer Recruitment 2025: 3,500 पदों पर भर्तियां, अंतिम तिथि 11 अगस्त
    AIIMS Nursing Officer Recruitment 2025: 3,500 पदों पर भर्तियां, अंतिम तिथि 11 अगस्त
    5 August 2025
    UP TGT (LT Grade Teacher) भर्ती – 7,466 पदों की जानकारी
    UP TGT (LT Grade Teacher) भर्ती – 7,466 पदों की जानकारी
    5 August 2025
    IB Security Assistant भर्ती 2025: 10वीं पास के लिए 4,987 पद, आवेदन की अंतिम तिथि 17 अगस्त
    IB Security Assistant भर्ती 2025: 10वीं पास के लिए 4,987 पद, आवेदन की अंतिम तिथि 17 अगस्त
    5 August 2025
Search
© 2025 News Jagran Network. All Rights Reserved.
Reading: Not Just Pharmacy: How Medkart is Building India’s Smartest Generic Medicine App
Share
Notification Show More
Font ResizerAa
NewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोतNewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोत
Font ResizerAa
  • मनोरंजन
  • फाइनेंस
  • एजुकेशन
Search
  • मनोरंजन
  • फाइनेंस
  • एजुकेशन
Follow US
© 2024 News Jagran. All Rights Reserved.
NewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोत > Blog > Business News > Not Just Pharmacy: How Medkart is Building India’s Smartest Generic Medicine App
Business News

Not Just Pharmacy: How Medkart is Building India’s Smartest Generic Medicine App

newsjagran.in
Last updated: 2025/08/05 at 3:58 PM
newsjagran.in
Share
5 Min Read
SHARE

India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the world’s largest medicine markets, millions of Indian families continue to struggle with the high cost of treatment. Studies show that over 50% of healthcare expenses in India are still paid out-of-pocket, leaving many to either delay care or make painful trade-offs between health and household priorities. In this environment, the need for accessible and affordable options is critical. This is where smart, tech-enabled platforms focused on generic medicines are stepping up. The growing shift toward generics, supported by stricter manufacturing standards and better public awareness, is unlocking a new healthcare era for India, one where savings don’t have to mean sacrifice.

Choosing Branded Generics Made Simple & Easy

The Industry Context: Healthcare Costs and E-Pharmacy Boom
India’s healthcare system places a significant financial burden on individuals, with many patients still covering treatment costs themselves. According to the National Health Accounts Estimates 2021-22 released by the Ministry of Health and Family Welfare, out-of-pocket expenditure accounted for approximately 39.4% of total health spending, down from 62.6% in 2014-15, but still substantial. This is particularly challenging for families managing chronic conditions like diabetes or hypertension, where monthly medicine expenses quickly add up but there is hardly any insurance that covers it. Meanwhile, a widespread lack of awareness persists: many patients are still unaware that most branded drugs have affordable generic counterparts, regulated for safety and efficacy by India’s pharmaceutical standards.

Moreover, while generic medicines make up nearly 70% of India’s pharma volume, a persistent perception problem remains: Are they as good as brands Can they be trusted These doubts, often fueled by misinformation and inconsistent supply chains, have kept many patients from making the switch.

Medkart is changing that.

What Medkart Solves: A System Plagued by Price Confusion and Inequity

Despite the availability of generics, most Indian consumers continue to purchase costly branded medicines due to a lack of information, trust, or local access. Chronic disease patients – especially those with diabetes or hypertension, which account for approximately 68% of India’s chronic illness burden are hit hardest by monthly bills.

Many tier-2 and rural customers also struggle with access. A patient needing basic chronic meds often travels kilometres, pays for branded substitutes, and ends up spending nearly 30% of household income on drugs alone.

Medkart: India’s Smartest Generic App Platform

Medkart’s app is designed as the simplest platform to use for smart medicine buying

  • Generic Medicine Comparison Engine: India’s first price-comparison tool for generics lets users compare prices and compositions instantly. Voriconazole, a multipurpose drug, shows savings of up to 86% (MRP Rs. 5,192 vs Medkart’s price Rs. 720).

  • Chronic Disease Navigation: Medicines are categorised into disease buckets (Diabetes, BP, Kidney, Heart), aligned with India’s leading disease burdens.

  • Prescription Upload & Matching: Users upload their prescription, and the app matches it with “Medkart Assured” generics, tested for Schedule M compliance and plant-audited.

  • WhatsApp Integration: With nearly 600M Indian WhatsApp users, Medkart offers order placement via WhatsApp, breaking digital barriers for older and rural patients.

  • Store + Delivery Hybrid Model: With 100+ retail stores and coverage across 35,000+ pin codes, Medkart offers online delivery with COD or many ways to pay.

Scale and Impact

  • Savings Delivered: Rs. 650 crore saved across 11+ lac users

  • Reach: 60 lakh orders fulfilled; 11+ Lac families served

  • Coverage: 35,000+ pincodes – deeper than most e-pharmacies

  • App Features: Available in Hindi, English, and Gujarati

Smarter Pharmacy, Healthier India
With India’s generic medicine market gaining momentum and digital health adoption rising across Tier 2 and Tier 3 cities, Medkart is bridging critical gaps in access, trust, and affordability. Its transparent pricing, disease-specific drug discovery, and hybrid delivery-retail model empower patients to make informed choices without compromising on quality.

As the demand for affordable healthcare surges, Medkart is not just responding, its reshaping how India buys medicines. By building India’s smartest generic pharmacy platform, Medkart is making quality healthcare both accessible and sustainable for millions.

Switch smart, save more. Download the Medkart App or visit www.medkart.in to explore up to 85% savings on generics.

Medkart – Aapka Shubhchintak.

You Might Also Like

Thiruvananthapuram Gets Smarter with TSCCC Boosting Traffic and Safety

Aspect Sports Acquires Varanasi Mahadev Ascenders for Pro Govinda League 2025

Signature Global Infinity Mall, Sohna: हाई-स्ट्रीट रिटेल और प्री-लीज़ कमर्शियल स्पेस में शानदार निवेश अवसर

गुरुग्राम और सोहना में सर्कल रेट्स में भारी बढ़ोतरी – घर खरीदारों पर बढ़ा स्टांप ड्यूटी का बोझ

Biostadt Gets a Fresh Identity with dojo – Badhna Zaroori Hai

Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article Biostadt Gets a Fresh Identity with dojo – Badhna Zaroori Hai
Next Article शानवास बने मराठी सिनेमा के यादगार चेहरे — निधन 71 वर्ष की आयु में शानवास बने मराठी सिनेमा के यादगार चेहरे — निधन 71 वर्ष की आयु में
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Latest News

DSSSB Non-Teaching भर्ती 2025: 600+ पदों पर आवेदन शुरू, 10वीं पास के लिए सुनहरा मौका
DSSSB Non-Teaching भर्ती 2025: 600+ पदों पर आवेदन शुरू, 10वीं पास के लिए सुनहरा मौका
एजुकेशन 5 August 2025
BSF Constable Tradesman भर्ती 2025: 3,588 पदों पर निकली वैकेंसी, आवेदन की अंतिम तिथि 23 अगस्त
BSF Constable Tradesman भर्ती 2025: 3,588 पदों पर निकली वैकेंसी, आवेदन की अंतिम तिथि 23 अगस्त
एजुकेशन 5 August 2025
AIIMS Nursing Officer Recruitment 2025: 3,500 पदों पर भर्तियां, अंतिम तिथि 11 अगस्त
AIIMS Nursing Officer Recruitment 2025: 3,500 पदों पर भर्तियां, अंतिम तिथि 11 अगस्त
एजुकेशन 5 August 2025
GNG Electronics IPO: ₹355 पर दमदार लिस्टिंग, 150 गुना सब्सक्रिप्शन – निवेशकों के लिए क्या है अगला कदम?
GNG Electronics IPO: ₹355 पर दमदार लिस्टिंग, 150 गुना सब्सक्रिप्शन – निवेशकों के लिए क्या है अगला कदम?
फाइनेंस 5 August 2025

महत्वपूर्ण पृष्ठ

  • मनोरंजन
  • फाइनेंस
  • एजुकेशन

त्वरित लिंक्स

  • Business News
  • प्रॉपर्टी इन सोहना
  • 8 वेतन आयोग
  • PM kisan
  • टेक्नोलॉजी

Discover News Jagran

  • Disclaimer
  • Fact-Checking Policy
  • Contact Us
  • About Us
Weather
23°C
Delhi
haze
23° _ 23°
53%
3 km/h
NewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोतNewsJagran.in | भारत की ताज़ा हिंदी खबरों का भरोसेमंद स्रोत
© 2025 News Jagran Network. All Rights Reserved.
  • मनोरंजन
  • फाइनेंस
  • एजुकेशन
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?